Diabetes Research and Clinical Practice
Volume 87, Issue 1 , Pages 4-14 , January 2010

Global estimates of the prevalence of diabetes for 2010 and 2030

  • J.E. Shaw

      Affiliations

    • Corresponding Author InformationCorresponding author at: Epidemiology, Baker IDI Heart and Diabetes Institute, 250 Kooyong Road, Caulfield, Melbourne, Victoria 3162, Australia. Tel.: +61 3 9258 5047; fax: +61 3 9258 5090.
    • ,
  • R.A. Sicree
    • ,
  • P.Z. Zimmet

Received 1 October 2009 ,Accepted 12 October 2009.

References 

  1. King H, Rewers M. Global estimates for prevalence of diabetes mellitus and impaired glucose tolerance in adults. Diabetes Care. 1993;16(1):157–177
  2. King H, Aubert R, Herman W. Global burden of diabetes, 1995–2025: prevalence, numerical estimates and projections. Diabetes Care. 1998;21(9):1414–1431
  3. Amos A, McCarty D, Zimmet P. The rising global burden of diabetes and its complications: estimates and projections to the year 2010. Diabet. Med. 1997;14(Suppl. 5):S1–S85
  4. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27(5):1047–1053
  5. International Diabetes Federation . Diabetes Atlas. 2nd ed.. Brussels: International Diabetes Federation; 2003;
  6. International Diabetes Federation . Diabetes Atlas. 3rd ed.. Brussels: International Diabetes Federation; 2006;
  7. World Health Organization, Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Department of Noncommunicable Disease Surveillance, Geneva, 1999. Report No.: WHO/NCD/NCS/99.2.
  8. World Health Organization, Diabetes mellitus: report of a WHO Study Group. Technical Report Series 727. WHO, Geneva, 1985.
  9. American Diabetes Association . Report of the Expert Committee on the diagnosis and classification of diabetes mellitus. Diabetes Care. 1997;20:1183–1197
  10. World Health Organization, Expert Committee on diabetes mellitus, second report. Technical Report Series 646. WHO, Geneva, 1980.
  11. World Health Organization, Prevention of diabetes mellitus. Technical Report Series no. 844. World Health Organization, Geneva, 1994.
  12. United Nations, Population Division, World Population Prospects: The 2006 Revision. United Nations (Ed.). Geneva, 2007.
  13. B. Shah, K. Anand, P. Joshi, J. Mahanta, V. Mohan, K. Thankappan, et al. Report of the surveillance of risk factors of non-communicable diseases (STEPS 1 and 2) from five centres in India—WHO India-ICMR initiative. New Delhi: http://www.whoindia.org/LinkFiles/NCD_Surveillance_NCD_RF_surveillance_report.pdf2004.
  14. Sadikot SM, Nigam A, Das S, Bajaj S, Zargar AH, Prasannakumar KM, et al. The burden of diabetes and impaired glucose tolerance in India using the WHO 1999 criteria: prevalence of diabetes in India study (PODIS). Diabetes Res. Clin. Pract. 2004;66(3):301–307
  15. Ramachandran A, Snehalatha C, Kapur A, Vijay V, Mohan V, Das AK, et al. High prevalence of diabetes and impaired glucose tolerance in India: National Urban Diabetes Survey. Diabetologia. 2001;44(9):1094–1101
  16. Gu D, Reynolds K, Duan X, Xin X, Chen J, Wu X, et al. Prevalence of diabetes and impaired fasting glucose in the Chinese adult population: International Collaborative Study of Cardiovascular Disease in Asia (InterASIA). Diabetologia. 2003;46(9):1190–1198
  17. Cowie CC, Rust KF, Ford ES, Eberhardt MS, Byrd-Holt DD, Li C, et al. Full accounting of diabetes and pre-diabetes in the U.S. population in 1988–1994 and 2005–2006. Diabetes Care. 2009;32(2):287–294
  18. Ramachandran A, Snehalatha C, Latha E, Manoharan M, Vijay V. Impacts of urbanisation on the lifestyle and on the prevalence of diabetes in native Asian Indian population. Diabetes Res. Clin. Pract. 1999;44(3):207–213
  19. Pan X-R, Yang W-Y, Li G-W, Lui J The National Diabetes Prevention and Control Cooperative Group. Prevalence of diabetes and its risk factors in China. Diabetes Care. 1997;20:1664–1669
  20. Cowie CC, Rust KF, Byrd-Holt DD, Eberhardt MS, Flegal KM, Engelgau MM, et al. Prevalence of diabetes and impaired fasting glucose in adults in the U.S. population: National Health and Nutrition Examination Survey 1999–2002. Diabetes Care. 2006;29(6):1263–1268
  21. Pan X, Li G, Hu Y, Wang J, Yang W, An Z, et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance: the Da Qing IGT and Diabetes Study. Diabetes Care. 1997;20:537–544
  22. Ramachandran A, Snehalatha C, Mary S, Mukesh B, Bhaskar AD, Vijay V. The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1). Diabetologia. 2006;49(2):289–297
  23. Vilbergsson S, Sigurdsson G, Sigvaldason H, Hreidarsson A, Sigfusson N. Prevalence and incidence of NIDDM in Iceland: evidence for stable incidence among males and females 1967–1991—the Reykjavik Study. Diabet. Med. 1997;14:491–498
  24. Satman I, Yilmaz T, Sengul A, Salman S, Salman F, Uygur S, et al. Population-based study of diabetes and risk characteristics in Turkey: results of the Turkish diabetes epidemiology study (TURDEP). Diabetes Care. 2002;25(9):1551–1556
  25. McLarty D, Kitange H, Mtinangi B, Makene W, Swai A, Masuki G, et al. Prevalence of diabetes and impaired glucose tolerance in rural Tanzania. Lancet. 1989;871–874
  26. Aspray TJ, Mugusi F, Rashid S, Whiting D, Edwards R, Alberti KG, et al. Rural and urban differences in diabetes prevalence in Tanzania: the role of obesity, physical inactivity and urban living. Trans. R. Soc. Trop. Med. Hyg. 2000;94(6):637–644
  27. Amoah AG, Owusu SK, Adjei S. Diabetes in Ghana: a community based prevalence study in Greater Accra. Diabetes Res. Clin. Pract. 2002;56(3):197–205
  28. Omar M, Seedat M, Motala A, Dyer R, Becker P. The prevalence of diabetes mellitus and impaired glucose tolerance in a group of urban South African blacks. SAMJ. 1993;83:641–643
  29. Levitt N, Katzenellenbogen J, Bradshaw D, Hoffman M, Bonnici F. The prevalence and identification of risk factors for NIDDM in urban Africans in Cape Town, South Africa. Diabetes Care. 1993;16(4):601–607
  30. Erasmus RT, Blanco Blanco E, Okesina AB, Matsha T, Gqweta Z, Mesa JA. Prevalence of diabetes mellitus and impaired glucose tolerance in factory workers from Transkei, South Africa. SAMJ. 2001;91(2):157–160
  31. Motala AA, Esterhuizen T, Gouws E, Pirie FJ, Omar MA. Diabetes and other disorders of glycemia in a rural South African community: prevalence and associated risk factors. Diabetes Care. 2008;31(9):1783–1788
  32. Hussain A, Rahim MA, AzadKhan AK, Ali SM, Vaaler S. Type 2 diabetes in rural and urban population: diverse prevalence and associated risk factors in Bangladesh. Diabet. Med. 2005;22(7):931–936
  33. Sayeed MA, Mahtab H, AkterKhanam P, AbdulLatif Z, KeramatAli SM, Banu A, et al. Diabetes and impaired fasting glycemia in a rural population of Bangladesh. Diabetes Care. 2003;26(4):1034–1039
  34. Rahim MA, Hussain A, AzadKhan AK, Sayeed MA, KeramatAli SM, Vaaler S. Rising prevalence of type 2 diabetes in rural Bangladesh: a population based study. Diabetes Res. Clin. Pract. 2007;77(2):300–305
  35. King H, Keuky L, Seng S, Khun T, Roglic G, Pinget M. Diabetes and associated disorders in Cambodia: two epidemiological surveys. Lancet. 2005;366(9497):1633–1639
  36. Mohan V, Mathur P, Deepa R, Deepa M, Shukla DK, Menon GR, et al. Urban rural differences in prevalence of self-reported diabetes in India—the WHO-ICMR Indian NCD risk factor surveillance. Diabetes Res. Clin. Pract. 2008;80(1):159–168
  37. Ministry of Health, Republic of Indonesia, National Basic Health Research 2007, Official Report (translated from RISKESDAS 2007, Sidartawan Soegondo), Jakarta, 2008.
  38. Ohmura T, Ueda K, Kiyohara Y, Kato H, Nakayama K, Nomiyama K, et al. Prevalence of type 2 (non-insulin dependent) diabetes mellitus and impaired glucose tolerance in the Japanese general population: the Hisayama study. Diabetologia. 1993;36:1198–1203
  39. Sekikawa A, Eguchi H, Tominaga M, Igarashi K, Abe T, Manaka H, et al. Prevalence of type 2 diabetes mellitus and impaired glucose tolerance in a rural area of Japan. The Funagata diabetes study. J. Diabetes Complications. 2000;14(2):78–83
  40. Park Y, Lee H, Koh C, Min H, Yoo K, Kim Y, et al. Prevalence of diabetes and IGT in Yonchon County, South Korea. Diabetes Care. 1995;18(4):545–548
  41. Kim SM, Lee JS, Lee J, Na JK, Han JH, Yoon DK, et al. Prevalence of diabetes and impaired fasting glucose in Korea: Korean National Health and Nutrition Survey 2001. Diabetes Care. 2006;29(2):226–231
  42. Institute for Public Health, Ministry of Health Malaysia, Diabetes Mellitus, 2006.
  43. Ministry of Health, Vietnam, Follow-up study on diabetic complications in patients since their first presentation at National Hospital of Endocrinology, TaVan Binh (Ed.), Ha Noi, 2006.
  44. Singh DL, Bhattarai MD. High prevalence of diabetes and impaired fasting glycaemia in urban Nepal. Diabet. Med. 2003;20(2):170–171
  45. Karki P, Baral N, Lamsal M, Rijal S, Koner BC, Dhungel S, et al. Prevalence of non-insulin dependent diabetes mellitus in urban areas of eastern Nepal: a hospital based study. Southeast Asian J. Trop. Med. Public Health. 2000;31(1):163–166
  46. Shrestha UK, Singh DL, Bhattarai MD. The prevalence of hypertension and diabetes defined by fasting and 2-h plasma glucose criteria in urban Nepal. Diabet. Med. 2006;23(10):1130–1135
  47. Baltazar JC, Ancheta CA, Aban IB, Fernando RE, Baquilod MM. Prevalence and correlates of diabetes mellitus and impaired glucose tolerance among adults in Luzon, Philippines. Diabetes Res. Clin. Pract. 2004;64(2):107–115
  48. Katulanda P, Constantine GR, Mahesh JG, Sheriff R, Seneviratne RD, Wijeratne S, et al. Prevalence and projections of diabetes and pre-diabetes in adults in Sri Lanka—Sri Lanka Diabetes, Cardiovascular Study (SLDCS). Diabet. Med. 2008;25(9):1062–1069
  49. Chou P, Chen H, Hsiao K. Community-based epidemiological study on diabetes in Pu-Li, Taiwan. Diabetes Care. 1992;15(1):81–89
  50. Chou P, Liao M, Kuo H, Hsiao K, Tsai S. A population survey on the prevalence of diabetes in Kin-Hu, Kinmen. Diabetes Care. 1994;17(9):1055–1058
  51. Aekplakorn W, Stolk RP, Neal B, Suriyawongpaisal P, Chongsuvivatwong V, Cheepudomwit S, et al. The prevalence and management of diabetes in Thai adults: the international collaborative study of cardiovascular disease in Asia. Diabetes Care. 2003;26(10):2758–2763
  52. Dunstan DW, Zimmet PZ, Welborn TA, de Courten MP, Cameron AJ, Sicree RA, et al. The rising prevalence of diabetes and impaired glucose tolerance: the Australian Diabetes, Obesity and Lifestyle Study. Diabetes Care. 2002;25(5):829–834
  53. National Diabetes Service Scheme, Diabetes Australia, 2009 [cited 2009, 14/1/2009]. Available from: http://www.ndss.com.au/Australian-Diabetes-Map/Map/.
  54. Szurkowska M, Szybinski Z, Nazim A, Szafraniec K, Jedrychowski W. Prevalence of type II diabetes mellitus in population of Krakow. Pol. Arch. Med. Wewn. 2001;106(3):771–779
  55. Lopatynski J, Mardarowicz G, Nicer T, Szczesniak G, Krol H, Matej A, et al. The prevalence of type II diabetes mellitus in rural urban population over 35 years of age in Lublin region (Eastern Poland). Pol. Arch. Med. Wewn. 2001;106(3):781–786
  56. Ubink-Veltmaat LJ, Bilo HJ, Groenier KH, Houweling ST, Rischen RO, Meyboom-deJong B. Prevalence, incidence and mortality of type 2 diabetes mellitus revisited: a prospective population-based study in The Netherlands (ZODIAC-1). Eur. J. Epidemiol. 2003;18(8):793–800
  57. Lipscombe LL, Hux JE. Trends in diabetes prevalence, incidence, and mortality in Ontario, Canada 1995–2005: a population-based study. Lancet. 2007;369(9563):750–756
  58. Public Health Agency of Canada, Report from the National Diabetes Surveillance System: diabetes in Canada, 2008 [cited 2009, 1/2/2009].
  59. Mokan M, Galajda P, Pridavkova D, Tomaskova V, Sutarik L, Krucinska L, et al. Prevalence of diabetes mellitus and metabolic syndrome in Slovakia. Diabetes Res. Clin. Pract. 2008;81(2):238–242
  60. Kusnik-Joinville O, Weill A, Salanave B, Ricordeau P, Allemand H. Prevalence and treatment of diabetes in France: trends between 2000 and 2005. Diabetes Metab. 2008;34(3):266–272
  61. Gourdy P, Ruidavets JB, Ferrieres J, Ducimetiere P, Amouyel P, Arveiler D, et al. Prevalence of type 2 diabetes and impaired fasting glucose in the middle-aged population of three French regions—the MONICA study 1995–97. Diabetes Metab. 2001;27(3):347–358
  62. Rathmann W, Haastert B, Icks A, Lowel H, Meisinger C, Holle R, et al. High prevalence of undiagnosed diabetes mellitus in Southern Germany: target populations for efficient screening. The KORA survey 2000. Diabetologia. 2003;46(2):182–189
  63. Hauner H, Koster I, von Ferber L. Prevalence of diabetes mellitus and quality of care in Hesse, Germany, 1998–2004. Dtsch. Arztebl. 2007;104(41):A2799–A2805
  64. Hauner H, Hanisch J, Bramlage P, Steinhagen-Thiessen E, Schunkert H, Jockel KH, et al. Prevalence of undiagnosed type-2-diabetes mellitus and impaired fasting glucose in German primary care: data from the German Metabolic and Cardiovascular Risk Project (GEMCAS). Exp. Clin. Endocrinol. Diabetes. 2008;116(1):18–25
  65. Panagiotakos DB, Pitsavos C, Chrysohoou C, Stefanadis C. The epidemiology of type 2 diabetes mellitus in Greek adults: the ATTICA study. Diabet. Med. 2005;22(11):1581–1588
  66. Cricelli C, Mazzaglia G, Samani F, Marchi M, Sabatini A, Nardi R, et al. Prevalence estimates for chronic diseases in Italy: exploring the differences between self-report and primary care databases. J. Public Health Med. 2003;25(3):254–257
  67. Metelko Z, Pavlic-Renar I, Poljicanin T, Szirovitza L, Turek S. Prevalence of diabetes mellitus in Croatia. Diabetes Res. Clin. Pract. 2008;81(2):263–267
  68. Arteagoitia JM, Larranaga MI, Rodriguez JL, Fernandez I, Pinies JA. Incidence, prevalence and coronary heart disease risk level in known type 2 diabetes: a sentinel practice network study in the Basque Country, Spain. Diabetologia. 2003;46(7):899–909
  69. Castell C, Tresserras R, Serra J, Goday A, Lloveras G, Salleras L. Prevalence of diabetes in Catalonia (Spain): an oral glucose tolerance test-based population study. Diabetes Res. Clin. Pract. 1999;43(1):33–40
  70. Masia R, Sala J, Rohlfs I, Piulats R, Manresa JM, Marrugat J. Prevalence of diabetes mellitus in the province of Girona, Spain: the REGICOR study. Rev. Espanola Cardiol. 2004;57(3):261–264
  71. Valverde JC, Tormo MJ, Navarro C, Rodriguez-Barranco M, Marco R, Egea JM, et al. Prevalence of diabetes in Murcia (Spain): a Mediterranean area characterised by obesity. Diabetes Res. Clin. Pract. 2006;71(2):202–209
  72. Eliasson M, Lindahl B, Lundberg V, Stegmayr B. No increase in the prevalence of known diabetes between 1986 and 1999 in subjects 25–64 years of age in northern Sweden. Diabet. Med. 2002;19(10):874–880
  73. Harvey JN, Craney L, Kelly D. Estimation of the prevalence of diagnosed diabetes from primary care and secondary care source data: comparison of record linkage with capture–recapture analysis. J. Epidemiol. Community Health. 2002;56(1):18–23
  74. Gill GV, Ismail AA, Beeching NJ, Macfarlane SB, Bellis MA. Hidden diabetes in the UK: use of capture–recapture methods to estimate total prevalence of diabetes mellitus in an urban population. J. R. Soc. Med. 2003;96(7):328–332
  75. Department of Health , United Kingdom . Health Survey for England 2003: Risk Factors for Cardiovascular Disease. London: The Stationery Office; 2004;
  76. Forouhi NG, Merrick D, Goyder E, Ferguson BA, Abbas J, Lachowycz K, et al. Diabetes prevalence in England, 2001—estimates from an epidemiological model. Diabet. Med. 2006;23(2):189–197
  77. de Sereday MS, Gonzalez C, Giorgini D, De Loredo L, Braguinsky J, Cobenas C, et al. Prevalence of diabetes, obesity, hypertension and hyperlipidemia in the central area of Argentina. Diabetes Metab. 2004;30(4):335–339
  78. Oliveira J, Milech A, Franco L Prevalence TBCGotSoD. The prevalence of diabetes in Rio de Janeiro, Brazil. Diabetes Care. 1996;19(6):663–666
  79. Malerbi D, Franco L. Multicenter study of the prevalence of diabetes mellitus and impaired glucose tolerance in the urban Brazilian population aged 30–69 yr. Diabetes Care. 1992;15(11):1509–1516
  80. Torquato MT, Montenegro Junior RM, Viana LA, de Souza RA, Lanna CM, Lucas JC, et al. Prevalence of diabetes mellitus and impaired glucose tolerance in the urban population aged 30–69 years in Ribeirao Preto (Sao Paulo), Brazil. Sao Paulo Med. J. 2003;121(6):224–230
  81. Baechler R, Mujica V, Aqueveque X, Ramos L, Soto A. Prevalence of diabetes mellitus in the Seventh Region of Chile. Rev. Med. Chil. 2002;130(11):1257–1264
  82. Aschner P, King H, de Torrado M, Rodriguez B. Glucose intolerance in Colombia. Diabetes Care. 1993;16(1):90–93
  83. Wilks R, Rotimi C, Bennett F, McFarlane-Anderson N, Kaufman JS, Anderson SG, et al. Diabetes in the Caribbean: results of a population survey from Spanish Town, Jamaica. Diabet. Med. 1999;16(10):875–883
  84. Barcelo A, Daroca MC, Ribera R, Duarte E, Zapata A, Vohra M. Diabetes in Bolivia. Rev. Panam Salud Publica. 2001;10(5):318–323
  85. Aguilar-Salinas CA, Velazquez Monroy O, Gomez-Perez FJ, Gonzalez Chavez A, Esqueda AL, MolinaCuevas V, et al. Characteristics of patients with type 2 diabetes in Mexico: results from a large population-based nationwide survey. Diabetes Care. 2003;26(7):2021–2026
  86. Sanchez-Castillo CP, Velasquez-Monroy O, Lara-Esqueda A, Berber A, Sepulveda J, Tapia-Conyer R, et al. Diabetes and hypertension increases in a society with abdominal obesity: results of the Mexican National Health Survey 2000. Public Health Nutr. 2005;8(1):53–60
  87. Shera AS, Rafique G, Khawaja IA, Baqai S, King H. Pakistan National Diabetes Survey: prevalence of glucose intolerance and associated factors in Baluchistan province. Diabetes Res. Clin. Pract. 1999;44(1):49–58
  88. Shera AS, Rafique G, Khwaja IA, Ara J, Baqai S, King H. Pakistan National Diabetes survey: prevalence of glucose intolerance and associated factors in Shikarpur, Sindh Province. Diabet. Med. 1995;12(12):1116–1121
  89. Shera AS, Rafique G, Khwaja IA, Baqai S, Khan IA, King H, et al. Pakistan National Diabetes Survey prevalence of glucose intolerance and associated factors in North West Frontier Province (NWFP) of Pakistan. J. Pak. Med. Assoc. 1999;49(9):206–211
  90. Basit A, Hydrie MZ, Ahmed K, Hakeem R. Prevalence of diabetes, impaired fasting glucose and associated risk factors in a rural area of Baluchistan province according to new ADA criteria. J. Pak. Med. Assoc. 2002;52(8):357–360
  91. Malek R, Belateche F, Laouamri S, Hamdi-Cherif M, Touabti A, Bendib W, et al. Prevalence of type 2 diabetes mellitus and glucose intolerance in the Setif area (Algeria). Diabetes Metab. 2001;27(2 Pt 1):164–171
  92. Herman W, Ali M, Aubert R, Engelgau M, Kenny S, Gunter E, et al. Diabetes mellitus in Egypt: risk factors and prevalence. Diabet. Med. 1995;12:1126–1131
  93. Arab M. Epidemiology of diabetes mellitus in Egypt. Egypt. J. Diabetes. 1997;2(1):1–15
  94. Azizi F, Salehi P, Etemadi A, Zahedi-Asl S. Prevalence of metabolic syndrome in an urban population: Tehran Lipid and Glucose Study. Diabetes Res. Clin. Pract. 2003;61(1):29–37
  95. Ajlouni K, Jaddou H, Batieha A. Diabetes and impaired glucose tolerance in Jordan: prevalence and associated risk factors. J. Intern. Med. 1998;244(4):317–323
  96. King H, Abdullaev B, Djumaeva S, Nikitin V, Ashworth L, Dobo MG. Glucose intolerance and associated factors in the Fergana Valley, Uzbekistan. Diabet. Med. 1998;15(12):1052–1062
  97. King H, Djumaeva S, Abdullaev B, Gacic Dobo M. Epidemiology of glucose intolerance and associated factors in Uzbekistan: a survey in Sirdaria province. Diabetes Res. Clin. Pract. 2002;55(1):19–27
  98. Tazi MA, Abir-Khalil S, Chaouki N, Cherqaoui S, Lahmouz F, Srairi JE, et al. Prevalence of the main cardiovascular risk factors in Morocco: results of a National Survey, 2000. J. Hypertens. 2003;21(5):897–903
  99. El-Hazmi M, Warsy A, Al-Swailem A, Al-Swailem A, Sulaimani R. Diabetes mellitus as a health problem in Saudi Arabia. East. Mediter. Health J. 1998;4(1):58–67
  100. Al-Nozha MM, Al-Maatouq MA, Al-Mazrou YY, Al-Harthi SS, Arafah MR, Khalil MZ, et al. Diabetes mellitus in Saudi Arabia. Saudi Med. J. 2004;25(11):1603–1610
  101. Al-Nuaim AR. Prevalence of glucose intolerance in urban and rural communities in Saudi Arabia. Diabet. Med. 1997;14(7):595–602
  102. Elbagir M, Eltom M, Elmahadi E, Kadam I, Berne C. A population-based study of the prevalence of diabetes and impaired glucose tolerance in adults in Northern Sudan. Diabetes Care. 1996;19(10):1126–1128
  103. Bouguerra R, Alberti H, Salem LB, Rayana CB, Atti JE, Gaigi S, et al. The global diabetes pandemic: the Tunisian experience. Eur. J. Clin. Nutr. 2007;61(2):160–165
  104. Al-Habori M, Al-Mamari M, Al-Meeri A. Type II diabetes mellitus and impaired glucose tolerance in Yemen: prevalence, associated metabolic changes and risk factors. Diabetes Res. Clin. Pract. 2004;65(3):275–281

PII: S0168-8227(09)00432-X

doi: 10.1016/j.diabres.2009.10.007

Diabetes Research and Clinical Practice
Volume 87, Issue 1 , Pages 4-14 , January 2010

Article Tools

* Image Usage & Resolution